Broselow Resuscitation Tape Recall
ATTENTION! The 2025 Broselow tapes were recalled last year due to potentially lethal drug dose errors. Please see the link here for more information. If you need assistance to receive […]

The DEA has released new EMS specific rules for obtaining, administering, and documenting Schedule II–V controlled substances. The “Registering Emergency Medical Services Agencies Under the Protecting Patient Access to Emergency Medications Act of 2017” rule went into effect on March 09, 2026. EMS agency medical directors, system administrators, and personnel must familiarize themselves with these new DEA regulations to ensure continued compliance. Follow the link for more information on the rule changes.
There was a webinar covering the changes on March 10, 2026. Below is the video recording of that webinar.
ATTENTION! The 2025 Broselow tapes were recalled last year due to potentially lethal drug dose errors. Please see the link here for more information. If you need assistance to receive […]
The Bureau of Emergency Medical Services is pleased to announce the launch of our new website. This update is part of the Bureau’s recent transition from the Idaho Department of […]
The DEA has released new EMS specific rules for obtaining, administering, and documenting Schedule II–V controlled substances. The “Registering Emergency Medical Services Agencies Under the Protecting Patient Access to Emergency […]